Anulex Technologies, Inc., a privately held medical device manufacturer focusing on spinal disc Preservation & Anular Repair™ products, announced the commercial availability of the Xclose™ Plus Tissue Repair System at the AANS/CNS Joint Section on Disorders of the Spine and Peripheral Nerves meeting in Orlando, Florida.
The Xclose Plus Tissue Repair System incorporates a number of advances that greatly simplify implantation of the device, enhance the mechanical closure of the tissue and allow the surgeon to implant in more challenging tissue. These advances were accomplished with the development of Invisiloc™ Technology, a proprietary locking technology to reduce the total mass of the construct while enabling smooth tensioning of the system. Additionally, the combination of materials provides a more durable implant.
The Xclose system has been used in over 7,300 U.S. procedures to date. Xclose was cleared in September 2006 for use in soft tissue approximation for procedures such as general and orthopedic surgery. Xclose provides a simple, convenient method for treating the compromised soft tissue of the anulus fibrosus.
Commenting on these two milestones, Rich Lunsford, Anulex’s President and Chief Executive Officer, said, “The addition of Xclose Plus will provide for a significant improvement in the way our customers treat their patients. Surgeons will be able to address a greater array of patients and tissue quality situations with the new system. Additionally, we are excited that an increasing number of surgeons are adopting preservation and anular repair techniques into their discectomy procedures.”
Stem cell therapy safe and potentially beneficial for spinal cord injury patients